-
Models for open innovation in the pharmaceutical industry.
August 2, 2013 Editor 0
Models for open innovation in the pharmaceutical industry.
Drug Discov Today. 2013 Jul 25;
Authors: Schuhmacher A, Germann PG, Trill H, Gassmann O
Abstract
The nature of the pharmaceutical industry is such that the main driver for its growth is innovation. In view of the vast challenges that the industry has been facing for several years and, in particular, how to manage stagnating research and development (R&D) productivity, pharmaceutical companies have opened their R&D organizations to external innovation. Here, we identify and characterize four new types of open innovator, which we call ‘knowledge creator’, ‘knowledge integrator’, ‘knowledge translator’ and ‘knowledge leverager’, and which describe current open R&D models.
PMID: 23892183 [PubMed – as supplied by publisher]
Categories: PubMed
HE Mahama Urges African Govts to Invest in Agric Research How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.
Subscribe to our stories
Recent Posts
- Entrepreneurial Alertness, Innovation Modes, And Business Models in Small- And Medium-Sized Enterprises December 30, 2021
- The Strategic Role of Design in Driving Digital Innovation June 10, 2021
- Correction to: Hybrid mosquitoes? Evidence from rural Tanzania on how local communities conceptualize and respond to modified mosquitoes as a tool for malaria control June 10, 2021
- BRIEF FOCUS: Optimal spacing for groundnuts in smallholder farming systems June 9, 2021
- COVID-19 pandemic: impacts on the achievements of Sustainable Development Goals in Africa June 9, 2021
Categories
Archives
Popular Post-All time
- A review on biomass-based... 1k views
- Can blockchain disrupt ge... 808 views
- Apply Now: $500,000 for Y... 806 views
- Test Your Value Propositi... 759 views
- Prize-winning projects pr... 727 views